1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Alcoholism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feldstein, AE; Latchoumycandane, C; McIntyre, TM; McMullen, MR; Nagy, LE; Papouchado, BG; Pratt, BT; Yang, L; Zhang, R | 1 |
| Jakowec, DM; Neiman, J; Packham, MA; Rand, ML | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Alcoholism
| Article | Year |
|---|---|
Chronic alcohol exposure increases circulating bioactive oxidized phospholipids.
Topics: Administration, Oral; Alcoholism; Animals; Diet; Ethanol; Fatty Liver; Feeding Behavior; Humans; Liver; Oxidation-Reduction; Oxidative Stress; Phospholipids; Platelet Activating Factor; Rats; Rats, Wistar; Taurine; Time Factors; Tumor Necrosis Factor-alpha | 2010 |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal.
Topics: Adult; Aged; Alcoholism; Blood Platelets; Calcium; Ethanol; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Serotonin; Smoking; Stimulation, Chemical; Substance Withdrawal Syndrome; Thromboxane B2 | 1989 |